Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$0.68 - $1.11 $17,000 - $27,750
25,000 Added 250.0%
35,000 $24,000
Q4 2022

Feb 08, 2023

BUY
$0.58 - $1.2 $5,800 - $12,000
10,000 New
10,000 $7,000

Others Institutions Holding CGEN

About COMPUGEN LTD


  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $129M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Seaview Investment Managers LLC Portfolio

Follow Seaview Investment Managers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seaview Investment Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seaview Investment Managers LLC with notifications on news.